Abstract: The present invention relates to a PID/section filter which is adapted without any restriction to an ATSC standard or a DVB standard, comprising a processor module for detecting a PID and a TID by decoding the input transport stream, downloading the information requested by the viewer, and controlling the operation of the each system unit in order to store the information on a memory or ignores it, a PID comparing circuit module for comparing the PID value stored on an internal register with the PID value from the processor module, a download circuit module for downloading the extracted information among the decoded information by the processor module, and an external memory managing module for storing the information extracted in-accordance with the request of the viewer among the information decoded on the processor module.

Abstract: Disclosed is a carbamyl chloride of an aminoarylcarbonyl compound having the structural formula I: wherein R is an alkyl, alkenyl, or aryl group; A is an aryl (including heteroaryl) ring group; each R′ is independently an alkyl group which may form a ring with Z or Z′; p is 0, 1, 2, or 3; each Z, Z′, and Y is independently hydrogen or a substituent; and n is 0, 1, or 2.

Abstract: Disclosed is a photographic element containing a light sensitive silver halide emulsion layer having associated therewith a coupler represented by Formula I: ##STR1## wherein COUP is a coupler parent group capable of reacting with an oxidized developer to form a first dye and is bonded at a coupling position to the group ##STR2## wherein X is a or NSO.sub.2 R; R is an alkyl or aryl group; and DYE is a releasable second dye that is after release the same color as the first dye and is linked to OC.dbd.X by a moiety of the DYE having Formula (IA): ##STR3## wherein R.sup.2 is a substituent; provided there is contained in the coupler of Formula I at least one group of Formula IB:--L.sub.m --Sol IBwherein L is a divalent linking group and m is 0 or 1; and Sol is a group containing an acidic hydrogen selected from the group consisting of --ArOH, --NHSO.sub.2 R.sup.1 and --SO.sub.2 NHR.sup.1, in which AR is an aromatic group and each R.sup.

Abstract: A method of making an alkylaminoarylcarbonyl compound having Formula I: ##STR1## wherein R is an alkyl group;A is an aryl (including heteroaryl) ring;each R' is independently an alkyl group which may form a ring with Z or Z';p is 0, 1, 2, or 3;each Z, Z', and Y is independently hydrogen or a substituent; andn is 0, 1, or 2;comprising:(a) blocking the carbonyl function of an aminoarylcarbonyl compound via condensation with an active methylene compound(b) alkylating this blocked amniocarbonyl compound via reductive alkylation with an alkyl or aryl (including heteroaryl) carbonyl compound, and(c) deblocking of the blocked alkylaminoarylcarbonyl compound via base hydrolysis to regenerate the carbonyl function and give the desired alkylaminocarbonyl compound.

Abstract: There are described intermediates for the preparation of known pyrazoloazole photographic magenta dye forming couplers and processes for making and using these intermediates. The intermediates are low molecular weight compounds represented by the structure: ##STR1## wherein: R, X, R.sup.1 and Y are defined herein. The process for making these intermediates involves diazotizing a 5-amino-1H-pyrazole to produce a 5-diazo-1H-pyrazole, then condensing the diazotized product with an active methine or methylene compound having a pKa of 14 or less to produce a substituted hydrazone and then subjecting the hydrazone to cyclization and reduction, in either order.

Abstract: The invention is directed to a high-density dispersion nuclear fuel having spherical particles of an uranium alloy dispersed in a nonfissionable matrix. The alloy includes uranium and 4-9 wt % Q, wherein Q is selected from the group consisting of Mo, Nb, and Zr. A process of manufacturing the spherical particles is also disclosed.

Abstract: The present invention relates to a process for preparing human proinsulin which is represented as a following chemical formula(I): ##STR1## wherein, R is an amino acid residue or a peptide which is degradable enzymatically or chemically; and, X is a linkage of an amino group of A-1 in insulin A chain and a carboxyl group of B-30 in insulin B chain which can be separated from the A chain or the B chain enzymatically or chemically, provided that a region from A-1 to A-21 is the insulin A chain and a region from B-1 to B-30 is the insulin B chain. In accordance with the present invention, human recombinant insulin precursor can be simply manufactured with a good reproducibility, since dissolution, sulfonation, concentration, desalting and purification are remarkably simplified, while increasing the yield of refolding reaction.

Abstract: The present invention forms a intermediate layer between a conductive layer and BPSG layer. In one embodiment, this intermediate layer is a buffer layer that absorbs excess P ions from the BPSG layer to suppress the formation of bubbles and thereby prevent short circuits that may be caused due to the presence of bubbles in the BPSG layer. In the second embodiment the intermediate layer is a thin nitride layer, which prevents the conductive layer and BPSG layer from being in direct contact with each other to suppress the formation of bubbles and also prevent short circuits that may be caused due to the presence of bubbles in the BPSG layer.

Abstract: A method for preparing a 1-aryl-3-arylamino-2-pyrazolin-5-one comprises reacting an N-aryl-3-arylamino-3-oximinopropionamide with an acylating agent in an inert solvent, then heating in contact with a strong acid catalyst and a dehydrating agent in an inert solvent, and then heating in contact with an acid in water and a lower alkanol.

Abstract: A method for preparing 2-pyrazolin-5-ones from 1,2,4-oxadiazoles is described. The method comprises forming a liquid reaction system of a base catalyst and a 1,2,4-oxadiazole in an organic liquid reaction medium and heating the reaction system to a temperature sufficient to cause the 1,2,4-oxadiazole to be rearranged to a 2-pyrazolin-5-one.